NCT00541034View on ClinicalTrials.gov

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

pentostatin

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Astex Pharmaceuticals, Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER